Literature DB >> 20160638

Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.

Olivier Soubrane1, Antoine Brouquet, Stéphane Zalinski, Benoît Terris, Catherine Brézault, Vincent Mallet, François Goldwasser, Olivier Scatton.   

Abstract

BACKGROUND/
OBJECTIVE: Oxaliplatin-based chemotherapy induces sinusoidal obstruction syndrome (SOS) lesions in the nontumorous liver parenchyma, which may increase the risk of liver resection for colorectal liver metastases. The objective of this study was to evaluate the accuracy of aspartate aminotransferase to platelet ratio index (APRI) and FIB-4 scoring systems to predict chemotherapy-associated liver injury and to correlate the severity of sinusoidal injury with postoperative outcome.
METHODS: Between 1998 and 2007, 78 patients were operated for colorectal liver metastases after preoperative oxaliplatin-based chemotherapy. Grading of steatosis and SOS in the nontumorous liver parenchyma was obtained in these patients. Univariate analysis of 18 preoperative factors to predict SOS occurrence was performed as well as multivariate analysis. Relevance of preoperative platelet count level, transaminase levels, and fibrosis scoring systems were evaluated to predict high grade lesions of SOS using a receiving operative curve analysis. Ninety-day mortality and morbidity were studied according to SOS severity in 51 patients who underwent major liver resection.
RESULTS: Overall, pathologic examination showed high-grade lesions of SOS (SOS 2/3) in 46 (59%) patients. Univariate analysis showed that a low preoperative platelet count, elevated preoperative aspartate aminotransferase, short interval between chemotherapy and surgery were significant factors associated with high-grade lesions of SOS. Multivariate analysis showed that only the APRI score was an independent predictive factor for severe SOS. Receiving operative curve analysis revealed that the cut-off value predicting high-grade lesions of SOS with the best accuracy was an APRI score of 0.36 (area under the curve, 0.85; sensitivity, 87%; specificity, 69%). After major liver resection (n = 51), SOS 2/3 (n = 38) was associated with postoperative hepatic dysfunction (26/38 in SOS 2/3 vs. 3/13 in SOS 0/1; P = 0.004) and ascites (P = 0.03).
CONCLUSION: A low preoperative platelet count and high APRI score seem to be the most reliable indicators to predict SOS severity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20160638     DOI: 10.1097/SLA.0b013e3181c79403

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  46 in total

1.  A case of severe stenosis of hepatic veins and inferior vena cava with stomal variceal bleeding induced by oxaliplatin-based chemotherapy.

Authors:  Hayato Yamaguchi; Yoshihiro Furuichi; Yoshitaka Kasai; Hirohito Takeuchi; Yuu Yoshimasu; Katsutoshi Sugimoto; Ikuo Nakamura; Takao Itoi
Journal:  Clin J Gastroenterol       Date:  2018-01-09

2.  A standard definition of major hepatectomy: resection of four or more liver segments.

Authors:  Srinevas K Reddy; Andrew S Barbas; Ryan S Turley; Jennifer L Steel; Allan Tsung; J Wallis Marsh; David A Geller; Bryan M Clary
Journal:  HPB (Oxford)       Date:  2011-07       Impact factor: 3.647

3.  Chemotherapy-Associated Liver Injuries: Unmet Needs and New Insights for Surgical Oncologists.

Authors:  Luca Vigano; Martina Sollini; Francesca Ieva; Francesco Fiz; Guido Torzilli
Journal:  Ann Surg Oncol       Date:  2021-04-30       Impact factor: 5.344

4.  Liver angulometry: a simple method to estimate liver volume and ratios.

Authors:  Reza Kianmanesh; Tullio Piardi; Esther Tamby; Alina Parvanescu; Onorina Bruno; Elisa Palladino; Olivier Bouché; Simon Msika; Daniele Sommacale
Journal:  HPB (Oxford)       Date:  2013-03-08       Impact factor: 3.647

Review 5.  Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).

Authors:  Cathy Q Fan; James M Crawford
Journal:  J Clin Exp Hepatol       Date:  2014-10-30

6.  Effect of age on the development of chemotherapy-associated liver injury in colorectal cancer liver metastasis.

Authors:  Taiichi Wakiya; Daisuke Kudo; Keinosuke Ishido; Norihisa Kimura; Yuta Yakoshi; Yoshikazu Toyoki; Hiroshi Kijima; Kenichi Hakamada
Journal:  Mol Clin Oncol       Date:  2017-06-29

7.  Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.

Authors:  Roderich E Schwarz; Jordan D Berlin; Heinz J Lenz; Bernard Nordlinger; Laura Rubbia-Brandt; Michael A Choti
Journal:  HPB (Oxford)       Date:  2012-09-24       Impact factor: 3.647

8.  Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab.

Authors:  Catherine Hubert; Christine Sempoux; Yves Humblet; Marc van den Eynde; Francis Zech; Isabelle Leclercq; Jean-François Gigot
Journal:  HPB (Oxford)       Date:  2013-01-18       Impact factor: 3.647

9.  Magnetic resonance imaging flowmetry demonstrates portal vein dilatation subsequent to oxaliplatin therapy in patients with colorectal liver metastasis.

Authors:  Jozef Urdzik; Tomas Bjerner; Alkwin Wanders; Frans Duraj; Ulf Haglund; Agneta Norén
Journal:  HPB (Oxford)       Date:  2012-08-20       Impact factor: 3.647

10.  The Impact of Modern Chemotherapy and Chemotherapy-Associated Liver Injuries (CALI) on Liver Function: Value of 99mTc-Labelled-Mebrofenin SPECT-Hepatobiliary Scintigraphy.

Authors:  Stéphanie Truant; Clio Baillet; Viviane Gnemmi; Maxence Fulbert; Anthony Turpin; Sabrina Dardenne; Emmanuelle Leteurtre; Mehdi El Amrani; Sébastien Dharancy; Laurent Dubuquoy; Damien Huglo; Christophe Chesné; François-René Pruvot
Journal:  Ann Surg Oncol       Date:  2020-08-24       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.